Veklury Recalled

On Sept. 20, 2024, Gilead Sciences recalled one lot of Veklury^® (remdesivir) for injection 100mg/vial. A glass particle was found inside one of the vials which may cause local irritation or swelling upon injection. There is a risk that the glass particle could travel through the blood vessels, potentially leading to a stroke or death. Veklury is indicated for the treatment of COVID-19 in adult and pediatric patients weighing at least 1.5kg who are hospitalized or non-hospitalized patients who have mild to moderate COVID-19 and are at high risk for progression to severe COVID-19, which includes hospitalization or death. To read more about the recall, see here.